Glooko has made a name for itself in digital health circles with its data management tools for diabetes patients, and has now added artificial intelligence capabilities with an agreement to
Akili Interactive has agreed a merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I in a deal that will take it into public hands with a valuation
The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet's Verily Life Sciences in 2016.
The final numbers are in, and now it's official – digital health companies raked in a massive $57.2 billion in funding last year, beating prior records with a 79% increase over 2020.
